+33(0)1 42 54 60 64 | contact@welcomeurope.com

Horizon Europe – Tackling diseases (Two Stages) – 2022

Horizon Europe aims to strengthen the EU's science and technology base and the European Research Area (ERA), to boost Europe's innovation capacity, competitiveness and employment, and to deliver on citizens' priorities, supporting our socio-economic model and values.

2022-02-01
Detailed budget by topic below
Close

Appeal framework

Institution European Commission
Sectors Health
Beneficiaries
Regions Developing countries, European Economic Area, European Union
Details
  • Member States
  • Associated Countries
  • Low and middle-income countries

For more information: Click here


Content reserved for subscribers

Register for free to access the content

Free access to all information

Priorities and funded actions

TOPICS:

Open

  • HORIZON-HLTH-2022-DISEASE-06-04-two-stage: Development of new effective therapies for rare diseases
  • HORIZON-HLTH-2022-DISEASE-06-03-two-stage: Vaccines 2.0 – developing the next generation of vaccines
  • HORIZON-HLTH-2022-DISEASE-06-02-two-stage: Pre-clinical development of the next generation of immunotherapies for diseases or disorders with unmet medical needs
Financement

Amount per topic:

  • HORIZON-HLTH-2022-DISEASE-06-02-two-stage: 60 million euro
  • HORIZON-HLTH-2022-DISEASE-06-03-two-stage: 40 million euro
  • HORIZON-HLTH-2022-DISEASE-06-04-two-stage: 60 million euro

Test your eligibility

Other funds:

Aucune relation trouvée.

Similar news

8 June 2020

Europe’s 300 millions euros commitment for vaccines

Lire l'aticle